Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Drip flows over 30-45 minutes
A total of 4 million A375 cells were seeded in a 150-mm dish and, 24 h later, when the tumor cell population reached approximately 10 million, 30 million CD8 + primary human T cells expressing LaccID and a constitutive engineered receptor (TCR or CAR) or T cells expressing only LaccID (no TCR or CAR) were added to the culture, achieving an effector to target ratio of 3:1
Khng qu khi ni rng Serum Trng Da Medi-Peel chnh l gii php trn vn cho nhng ai ang gp vn vi da thm sm, nm v thiu sc sng
In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma
The vials are intended for research and laboratory use only
We recommend injections be administered once weekly for 4 weeks, followed by once a month
